BoneSupport Encouraged By Top-Line Data From CERTiFy Trial Of Cerament Bone Void Filler Injectable
Results of the CERTiFy study demonstrate Bonesupport's Cerament bone-void filler is non-inferior to autograft in treating tibia plateau fracture defects. The company says the study marks a major milestone for its business and will change the standard of care for this kind of injury.
You may also be interested in...
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.